Copper histidinate

Status:

Red

Decision Date:

December 2023

Comments

RED: SSC2577: Subcutaneous copper histidinate injections for presymptomatic neonates with classical Menkes disease as per NHSE commissioning intentions

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating

search again